Mergers and Acquisitions in the IVD Market

Attention: There is an updated edition available for this report.
   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990

Published Jan 10, 2017 | 60 Pages | Pub ID: KLI15221619

Mergers and Acquisitions in the IVD Market

In vitro diagnostic (IVD) testing is complex and companies often need to acquire the technology parts they lack to continue to compete successfully in the IVD market. In addition to looking to buy technology, the economic situation has resulted in companies buying partners outside of their home country and also to increase their market share and produce revenue growth. Therefore, merger activity was robust in 2016. Kalorama records in Mergers and Acquisitions in the IVD Market over 120 acquisitions in both the 2015-2016 and 2014-2013 periods, some 250 purchases in total.

Among the mergers and acquisitions activities discussed in the report are:
  • LabCorp’s purchase of Sequenom, a major player in the field of non-invasive prenatal testing (NIPT) for reproductive health.
  • Danaher Corporation’s purchase of Cepheid, a manufacturer of molecular systems and tests.
  • Bio-Techne’s acquisition of Advanced Cell Diagnostics (ACD), marking Bio-Techne’s entry into the genomics market.
  • Luminex’s acquisition of Nanosphere and the Verigene platform.
Top tier IVD companies who have been active in mergers and acquisitions include:
  • Roche
  • Siemens
  • Danaher
  • Abbott
  • Thermo Fisher Scientific
  • Beckman Coulter
  • Becton Dickinson (BD)
The industry goal is to build better tests and stronger companies. The future of the business lies in the development of more sensitive, faster, user-friendly, IT capable devices for a host of new protein and molecular markers. No company, big or small, owns all of the technology needed to develop these new tests and systems. They have to get the pieces they do not have via acquisitions and partnerships, activity that is expected to continue for at least the next 5-10 years.

The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.